Transplacental transfer of osimertinib and alectinib using an ex vivo human placental perfusion model
Placenta · 2026
DOI: 10.1016/j.placenta.2026.05.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Placenta, 2026. Verfasst von Laure Benoit und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre Hospitalier Intercommunal de Poissy Saint-Germain-en-Laye, Department of Gynecology and Obstetrics, Poissy, France; Université Paris-Saclay, U…. Hauptthemen laut MEDLINE: Carbazoles, Piperidines, Aniline Compounds, Acrylamides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The incidence of non-small cell lung cancer (NSCLC) is increasing in women, including those of childbearing age. While recent drugs such as osimertinib and alectinib have improved the prognosis of specific molecular subtypes (e.g., EGFR-mutant and ALK-rearranged NSCLC), their potential use during pregnancy remains inadequately supported by pharmacological data. OBJECTIVE: To assess the transplacental transfer and placental cotyledon accumulation of osimertinib and alectinib, using a human ex vivo placental perfusion model. STUDY DESIGN: Term placentas from normal pregnancies were collected after delivery and perfused with osimertinib or alectinib (in combination with alectinib major active metabolite M4) doses simulating steady state plasma concentrations observed in maternal plasma. Fetal transfer rate, clearance index, and cotyledon accumulation were evaluated, with antipyrine used as a control marker. Samples were collected during a 90-min procedure. RESULTS: Significant transplacental transfer of osimertinib was observed, with a fetal transfer rate of 9.5% and a CI of 0.41, and cotyledon accumulation of 28.9%. In contrast, neither alectinib nor M4 were detected in fetal samples, although both were found to accumulate substantially in placental tissues (370.7% and 178.3%, respectively). CONCLUSION: These findings suggest that osimertinib crosses the placenta with a moderate tissue uptake, while alectinib and its metabolite M4 do not appear to be transferred to the fetus but accumulate significantly within the placental tissue. Further studies are needed to guide treatment selection for NSCLC in pregnant women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre Hospitalier Intercommunal de Poissy Saint-Germain-en-Laye, Department of Gynecology and Obstetrics, Poissy, France; Université Paris-Saclay, UMR 1198, INRAE, BREED, RHuMA, Jouy-en-Josas, France. Electronic addres…
- Pharmacology Department, Gustave Roussy Institute, Villejuif, France; Pharmacokinetic Department, Faculté de Pharmacie, Université Paris-Saclay, Gif-sur-Yvette, France.
- Université Paris-Saclay, UMR 1198, INRAE, BREED, RHuMA, Jouy-en-Josas, France.
- Centre Hospitalier Intercommunal de Poissy Saint-Germain-en-Laye, Department of Gynecology and Obstetrics, Poissy, France; Université Paris-Saclay, UMR 1198, INRAE, BREED, RHuMA, Jouy-en-Josas, France; Université Paris-…
- Oncology Unit, Oncology Department, Gustave Roussy Institute, Villejuif, France.
- Université Paris-Saclay, UMR1173, Montigny-le-Bretonneux, 78180, France.
Zitieren
APA
Benoit, L., Combarel, D., Dieudonne, M. N., Rodriguez, Y., Heggarty, E., Mir, O., Grassin Delyle, S., Lamy, E., Paci, A., Vialard, F., & Berveiller, P. (2026). Transplacental transfer of osimertinib and alectinib using an ex vivo human placental perfusion model. Placenta. https://doi.org/10.1016/j.placenta.2026.05.024
Vancouver
Benoit L, Combarel D, Dieudonne MN, Rodriguez Y, Heggarty E, Mir O, et al. Transplacental transfer of osimertinib and alectinib using an ex vivo human placental perfusion model. Placenta. 2026. doi:10.1016/j.placenta.2026.05.024
BibTeX
@article{Benoit2026,
author = {Benoit, Laure and Combarel, David and Dieudonne, Marie-Noëlle and Rodriguez, Yoann and Heggarty, Estelle and Mir, Olivier and Grassin Delyle, Stanislas and Lamy, Elodie and Paci, Angelo and Vialard, François and Berveiller, Paul},
title = {Transplacental transfer of osimertinib and alectinib using an ex vivo human placental perfusion model},
journal = {Placenta},
year = {2026},
doi = {10.1016/j.placenta.2026.05.024}
}
EUVIMED